Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
STAT1
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) ==Publications== {{medline-entry |title=Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33112891 |abstract=The World Health Organization declared the COVID-19 epidemic a public health emergency of international concern on March 11th, 2020, and the pandemic is rapidly spreading worldwide. COVID-19 is caused by a novel coronavirus SARS-CoV-2, which enters human target cells via angiotensin converting enzyme 2 ([[ACE2]]). We used a number of bioinformatics tools to computationally characterize [[ACE2]] by determining its cell-specific expression in trachea, lung, and small intestine, derive its putative functions, and predict transcriptional regulation. The small intestine expressed higher levels of [[ACE2]] mRNA than any other organ. By immunohistochemistry, duodenum, kidney and testis showed strong signals, whereas the signal was weak in the respiratory tract. Single cell RNA-Seq data from trachea indicated positive signals along the respiratory tract in key protective cell types including club, goblet, proliferating, and ciliary epithelial cells; while in lung the ratio of [[ACE2]]-expressing cells was low in all cell types (<2.6%), but was highest in vascular endothelial and goblet cells. Gene ontology analysis suggested that, besides its classical role in the renin-angiotensin system, [[ACE2]] may be functionally associated with angiogenesis/blood vessel morphogenesis. Using a novel tool for the prediction of transcription factor binding sites we identified several putative binding sites within two tissue-specific promoters of the [[ACE2]] gene as well as a new putative short form of [[ACE2]]. These include several interferon-stimulated response elements sites for [[STAT1]], [[IRF8]], and [[IRF9]]. Our results also confirmed that age and gender play no significant role in the regulation of [[ACE2]] mRNA expression in the lung. |mesh-terms=* Aging * Angiotensin-Converting Enzyme 2 * Betacoronavirus * Binding Sites * COVID-19 * Carrier Proteins * Computational Biology * Coronavirus Infections * Female * Gene Expression Regulation, Enzymologic * Gene Ontology * Humans * Interferons * Lung * Male * Metalloproteases * Neovascularization, Physiologic * Organ Specificity * Pandemics * Peptidyl-Dipeptidase A * Pneumonia, Viral * Promoter Regions, Genetic * RNA, Messenger * Receptors, Virus * Renin-Angiotensin System * SARS-CoV-2 * Sex Characteristics * Single-Cell Analysis * Transcription Factors * Transcription Initiation Site * Virus Attachment |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592753 }} {{medline-entry |title=[[STAT1]]-p53-p21axis-dependent stress-induced progression of chronic nephrosis in adriamycin-induced mouse model. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32953802 |abstract=Chronic nephrosis (CN) is an aging-related disease with high mortality. Signal transduction and transcriptional activator 1 ([[STAT1]]) protein promotes senescence in human glomerular mesangial cells (HMCs), but whether it affects the progression of adriamycin (ADR)-induced CN [i]in vivo[/i] remains unclear. We established an ADR-induced CN mouse model that was completed in wild-type (wt) mice by a single intravenous injection of 10 mg/kg ADR for 2 or 4 weeks. Clinical indexes in each group were determined. Hematoxylin and eosin staining (H
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)